|
KMID : 1141720210090010001
|
|
폐쇄성폐질환
2021 Volume.9 No. 1 p.1 ~ p.5
|
|
|
|
|
Kim Hyun-Jung
|
|
|
Abstract
|
|
|
|
Patients with chronic obstructive pulmonary disease (COPD) or uncontrolled asthma have an increased risk of a more severe course of COVID-19 (coronavirus disease). These vulnerable patients should follow public health recommendations more carefully including hand washing and wearing masks. Although data is limited, the usual recommendations for the management of asthma and COPD remain valid. To maintain optimal control and prevent acute exacerbations, the best method is the maintenance of a proper pharmacological treatment. Therefore, patients should continue their usual medications including inhaled corticosteroids for asthma and eosinophilic COPD according to the prescription. It remains unclear whether systemic steroids are helpful or harmful in the treatment of COVID-19, however, using systemic steroids to treat acute exacerbations whether they are triggered by SARS-CoV-2 or not takes priority. During the COVID-19 pandemic, patients should take care of themselves and remain physically active and manage their anxiety and depression.
|
|
|
KEYWORD
|
|
|
Chronic obstructive pulmonary disease, Asthma, COVID-19, Inhaled corticosteroid, Acute exacerbation
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|